IL33 and pulmonary hypertension: In addition, Shelest et al. associated elevated IL-33 levels with a higher incidence of pulmonary hypertension (PH) in T2D patients with coronary artery disease, proposing IL-33 as a possible biomarker for cardiovascular complications [149].